Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Rimkus, Tadas
55  Ergebnisse:
Personensuche X
?
1

Correction: Interaction between STAT3 and GLI1/tGLI1 oncoge..:

Sirkisoon, Sherona R. ; Carpenter, Richard L. ; Rimkus, Tadas...
Oncogene.  , 2024
Link: https://doi.org/10.1038/..
 
?
2

BSCI-14. tGLI1 is an actionable therapeutic target in breas..:

Doheny, Daniel ; Manore, Sara ; Wong, Grace...
Neuro-Oncology Advances.  3 (2021)  Supplement_3 - p. iii4-iii4 , 2021
Link: https://doi.org/10.1093/..
 
?
3

Correction: TGLI1 transcription factor mediates breast canc..:

Sirkisoon, Sherona R. ; Carpenter, Richard L. ; Rimkus, Tadas...
Oncogene.  40 (2021)  12 - p. 2338-2338 , 2021
Link: https://doi.org/10.1038/..
 
?
4

54. tGLI1 IS AN ACTIONABLE THERAPEUTIC TARGET IN BREAST CAN..:

Doheny, Daniel ; Sirkisoon, Sherona ; Rimkus, Tadas...
Neuro-Oncology Advances.  2 (2020)  Supplement_2 - p. ii11-ii11 , 2020
Link: https://doi.org/10.1093/..
 
?
5

BSCI-13. TUMOR-SPECIFIC tGLI1 TRANSCRIPTION FACTOR MEDIATES..:

Sirkisoon, Sherona ; Carpenter, Richard ; Rimkus, Tadas...
Neuro-Oncology Advances.  1 (2019)  Supplement_1 - p. i3-i3 , 2019
Link: https://doi.org/10.1093/..
 
?
6

TGLI1 transcription factor mediates breast cancer brain met..:

Sirkisoon, Sherona R. ; Carpenter, Richard L. ; Rimkus, Tadas...
Oncogene.  39 (2019)  1 - p. 64-78 , 2019
Link: https://doi.org/10.1038/..
 
?
7

BSCI-02. tGLI1 IS A NOVEL, ACTIONABLE TARGET FOR THE TREATM..:

Doheny, Daniel ; Sirkisoon, Sherona ; Rimkus, Tadas...
Neuro-Oncology Advances.  1 (2019)  Supplement_1 - p. i1-i1 , 2019
Link: https://doi.org/10.1093/..
 
?
8

Interaction between STAT3 and GLI1/tGLI1 oncogenic transcri..:

Sirkisoon, Sherona R. ; Carpenter, Richard L. ; Rimkus, Tadas...
Oncogene.  37 (2018)  19 - p. 2502-2514 , 2018
Link: https://doi.org/10.1038/..
 
?
9

Combined inhibition of AKT and HSF1 suppresses breast cance..:

Carpenter, Richard L. ; Sirkisoon, Sherona ; Zhu, Dongqin...
Oncotarget.  8 (2017)  43 - p. 73947-73963 , 2017
Link: https://doi.org/10.18632..
 
?
10

Targeting the Sonic Hedgehog Signaling Pathway: Review of S..:

Rimkus, Tadas ; Carpenter, Richard ; Qasem, Shadi..
Cancers.  8 (2016)  2 - p. 22 , 2016
Link: https://doi.org/10.3390/..
 
?
11

NEDD4 degrades TUSC2 to promote glioblastoma progression:

Rimkus, Tadas K. ; Arrigo, Austin B. ; Zhu, Dongqin...
Cancer Letters.  531 (2022)  - p. 124-135 , 2022
Link: https://doi.org/10.1016/..
 
?
12

BSCI-14. tGLI1 is an actionable therapeutic target in breas..:

Doheny, Daniel ; Manore, Sara ; Wong, Grace...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351283/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

54. tGLI1 IS AN ACTIONABLE THERAPEUTIC TARGET IN BREAST CAN..:

Doheny, Daniel ; Sirkisoon, Sherona ; Rimkus, Tadas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401397/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

TGLI1 transcription factor mediates breast cancer brain met..:

Sirkisoon, Sherona R ; Carpenter, Richard L ; Rimkus, Tadas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938539/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
15

BSCI-02. tGLI1 IS A NOVEL, ACTIONABLE TARGET FOR THE TREATM..:

Doheny, Daniel ; Sirkisoon, Sherona ; Rimkus, Tadas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213346/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
1-15